Image-guided therapy developer IMRIS has received the CE Mark for its Visius iCT ceiling-mounted intraoperative CT scanner.
IMRIS will now begin sales and marketing of Visius iCT in the EU. The company received U.S. Food and Drug Administration (FDA) 510(k) clearance in July, and has sold systems to three U.S. neurosciences centers. Installations are in progress at two of these centers, IMRIS said.
